Literature DB >> 33466345

Prevalence and Antimicrobial Susceptibility Profiles of Microorganisms Associated with Lower Reproductive Tract Infections in Women from Southern Poland-Retrospective Laboratory-Based Study.

Jadwiga Wójkowska-Mach1, Monika Pomorska-Wesołowska2, Małgorzata Romanik3, Dorota Romaniszyn1.   

Abstract

OBJECTIVE: Female infections affecting the genital tract include sexually transmitted diseases, endogenous infections such as vulvovaginal candidiasis, bacterial vaginosis (BV) or aerobic vaginitis (AV) and healthcare-associated infections. The aim of the study was to analyze the etiological factors of the vaginal dysbacteriosis, and the antimicrobial susceptibility of the dominant bacterial and fungal infections in different age groups of outpatient women from the Silesian Region.
MATERIALS AND METHODS: A retrospective laboratory-based multi-center study encompassed 4994 women of different ages in Silesian Voivodeship, in the south of Poland; patients who had vaginal swabs collected as per physicians' orders during the period from 1 January 2017 until 30 June 2018 were included in the study. The inclusion criteria were: non-hospitalized female, aged ≤80, with suspected vulvovaginal candidiasis or bacterial vaginosis and clinical sings of infections.
RESULTS: Gram-positive cocci were the ones most often isolated: Enterococcus faecalis (29.2%) and Streptoccoccus agalactiae (13.1%), followed by bacilli from the Enterobacteriaceae group, including Escherichia coli (26.3%). The presence of Streptococcus agalactiae was confirmed in 13.1%, slightly more often in the 45-80 age group, and Gardnerella vaginalis in 6.4%, most often in women aged 15-24. The prevalence of yeast-like infections was 24.3%, Candida albicans accounted for 78.3%, whereas among C. non-albicans spp.-C. glabrata dominated (14.9%) followed by C. parapsilosis (3.8%). The highest resistance was observed only in Streptococcus agalactiae as the MLSB mechanism (Macrolide-lincosamide-streptogramin B) was identified in 38.6% of strains. The prevalence of vulvovaginal candidiasis was 24.3%, the highest in women aged 15-44.
CONCLUSIONS: Drug resistance in studied vulvovaginitis was associated only with Streptococcus agalactiae. A high proportion of yeast-like aetiology was found, probably associated with recurrent infections. In the analyzed cases only the Amsel criteria and culture methods were used for diagnosis without preparations and microbiological Nugent criteria.

Entities:  

Keywords:  Candida spp.; Escherichia coli; lower genital tract; vaginal infections

Mesh:

Year:  2021        PMID: 33466345      PMCID: PMC7794702          DOI: 10.3390/ijerph18010335

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  30 in total

1.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

Authors:  Jennifer R Verani; Lesley McGee; Stephanie J Schrag
Journal:  MMWR Recomm Rep       Date:  2010-11-19

2.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Authors:  Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

3.  Aerobic vaginitis: no longer a stranger.

Authors:  Gilbert G G Donders; Gert Bellen; Svitrigaile Grinceviciene; Kateryna Ruban; Pedro Vieira-Baptista
Journal:  Res Microbiol       Date:  2017-05-11       Impact factor: 3.992

4.  Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.

Authors:  Damien Subtil; Gilles Brabant; Emma Tilloy; Patrick Devos; Frédérique Canis; Annie Fruchart; Marie-Christine Bissinger; Jean-Charles Dugimont; Catherine Nolf; Christophe Hacot; Sophie Gautier; Jérôme Chantrel; Marielle Jousse; David Desseauve; Jean Louis Plennevaux; Christine Delaeter; Sylvie Deghilage; Anne Personne; Emmanuelle Joyez; Elisabeth Guinard; Eric Kipnis; Karine Faure; Bruno Grandbastien; Pierre-Yves Ancel; François Goffinet; Rodrigue Dessein
Journal:  Lancet       Date:  2018-10-12       Impact factor: 79.321

5.  Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications.

Authors:  J D Sobel; M Zervos; B D Reed; T Hooton; D Soper; P Nyirjesy; M W Heine; J Willems; H Panzer
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

6.  Bacterial infections of the lower genital tract in fertile and infertile women from the southeastern Poland.

Authors:  Anna Tomusiak; Piotr Bogumił Heczko; Jarosław Janeczko; Paweł Adamski; Magdalena Pilarczyk-Zurek; Magdalena Strus
Journal:  Ginekol Pol       Date:  2013-05       Impact factor: 1.232

7.  Carriage of group B streptococci in pregnant women from the region of Krakow and their antibiotic resistance in the years 2008-2012.

Authors:  Monika Brzychczy-Włoch; Dorota Ochońska; Małgorzata Bulanda
Journal:  Pol J Microbiol       Date:  2013

8.  Comparative Study on the Vaginal Flora and Incidence of Asymptomatic Vaginosis among Healthy Women and in Women with Infertility Problems of Reproductive Age.

Authors:  Geethavani Babu; Balamuru Ganvelu Singaravelu; R Srikumar; Sreenivasalu V Reddy; Afraa Kokan
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 9.  Candidiasis and Mechanisms of Antifungal Resistance.

Authors:  Somanon Bhattacharya; Sutthichai Sae-Tia; Bettina C Fries
Journal:  Antibiotics (Basel)       Date:  2020-06-09

10.  Incidence of maternal GBS colonization and neonatal GBS disease among very low birth weight Polish neonates.

Authors:  Monika Brzychczy-Wloch; Jadwiga Wojkowska-Mach; Ewa Helwich; Piotr B Heczko
Journal:  Med Sci Monit       Date:  2013-01-11
View more
  1 in total

Review 1.  The pathogenesis of prevalent aerobic bacteria in aerobic vaginitis and adverse pregnancy outcomes: a narrative review.

Authors:  Xiaotong Ma; Ming Wu; Chen Wang; Huiyang Li; Aiping Fan; Yingmei Wang; Cha Han; Fengxia Xue
Journal:  Reprod Health       Date:  2022-01-28       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.